Magnifying glass in front of a stack of files of papers
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy
The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.
ABOVE: © ISTOCK.COM, BERNIE_PHOTO
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy

The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.

The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.

ABOVE: © ISTOCK.COM, BERNIE_PHOTO

journal retraction

Magazines and stethoscope
Q&A: Potential Partiality in Scientific Publishing
Chloe Tenn | Nov 23, 2021
The Scientist interviewed clinical pharmacologist Clara Locher, coauthor of a new survey aimed at detecting editorial bias, regarding her team’s findings about biomedical publishing.
A conceptual illustration of computers, hands on mice, a virus
A Surge in Pandemic Research Shines a Spotlight on Preprints
Diana Kwon | Sep 10, 2021
Many scientists have turned to preprints to rapidly disseminate their research on COVID-19, but some disagree with this approach.
an illustration of the earth with lines illustrating its geomagnetic fields
Paper Proposing COVID-19, Magnetism Link to Be Retracted
Shawna Williams | Nov 4, 2020
The study, published in a peer-reviewed journal, has attracted widespread derision from researchers.
Timeline: When Bad Research Changes Public Health Strategy
Catherine Offord | Oct 1, 2020
Illinois-based Surgisphere Corporation had a brief moment in the limelight this year following its infamous study of hydroxychloroquine. But the impact of the company’s deception reverberated across world.
The Surgisphere Scandal: What Went Wrong?
Catherine Offord | Oct 1, 2020
The high-profile retractions of two COVID-19 studies stunned the scientific community earlier this year and prompted calls for reviews of how science is conducted, published, and acted upon. The warning signs had been there all along.
The Lancet Alters Editorial Practices After Surgisphere Scandal
Catherine Offord | Sep 22, 2020
The changes, which affect the declarations authors have to sign and the peer-review process, have received a mixed response from the scientific community.
Paper Used in Creationist Teaching Retracted After 30 Years
Ashley Yeager | Nov 11, 2019
Criticism of the paper first surfaced in 1994, and its author was accused of scientific misconduct.
Nature Retracts Paper on Delivery System for CAR T Immunotherapy
Diana Kwon | Feb 20, 2019
The manuscript had amassed more than 50 comments about problematic figures and data on PubPeer.
JAMA Journals Retract Six Papers by Cornell Researcher
Ashley Yeager | Sep 19, 2018
Problems with Brian Wansink’s research articles surfaced in 2017 and have now resulted in 13 retractions total.
Study: 35,000 Papers May Have Retraction-Worthy Image Duplication
Catherine Offord | Jun 29, 2018
The authors of a preprint recommend that journals implement better image screening procedures before publishing articles.
Italian Scientist’s Retraction Count Hits 15
Diana Kwon | Mar 5, 2018
Alfredo Fusco, a once prominent cancer researcher, has been under investigation for alleged research misconduct since 2012.
Kyoto University Finds Stem Cell Researcher Guilty of Data Fabrication
Katarina Zimmer | Jan 24, 2018
The scientist was a member of a stem cell research team led by Nobel laureate Shinya Yamanaka. 
Mass Resignation from Scientific Reports’s Editorial Board
Catherine Offord | Nov 6, 2017
Nineteen researchers have stepped down after the journal decided not to retract a paper that they say plagiarized the work of a Johns Hopkins biomedical scientist.
Oncotarget Journal Cut from Medline
Katarina Zimmer | Oct 26, 2017
New papers from a cancer journal once named as a possibly predatory publication will no longer appear in the widely used research database.
Retractions Damage Scientists’ Reputations: Study
Aggie Mika | Sep 8, 2017
Authors of rescinded papers see a 10 percent to 20 percent decline in citation rates for their other publications.